1. 1) Prince M., Comas-Herrera A., Knapp M., Guerchet M. and Karagiannidou M. (2016) World Alzheimer Report 2016. Alzheimer's Disease International, London.
2. 2) Working report from Ministry of Health, Labour and Welfare of Japan (2015) “Nihon ni okeru ninchisho no koureisya jinkou no syouraisuikei ni kansuru kenkyuu” (in Japanese).
3. 3) Glenner, G.G. and Wong, C.W. (1984) Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885–890.
4. 4) Masters, C.L., Simms, G., Weinman, N.A., Multhaup, G., Mcdonald, B.L. and Beyreuther, K. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. U.S.A. 82, 4245–4249.
5. 5) Kosik, K.S., Joachim, C.L. and Selkoe, D.J. (1986) Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 83, 4044–4048.